These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34745228)

  • 1. The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time.
    Rosendahl Huber A; Van Hoeck A; Van Boxtel R
    Front Genet; 2021; 12():760039. PubMed ID: 34745228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
    Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
    Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics.
    Burgio E; Piscitelli P; Colao A
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30127322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational signatures and mutable motifs in cancer genomes.
    Rogozin IB; Pavlov YI; Goncearenco A; De S; Lada AG; Poliakov E; Panchenko AR; Cooper DN
    Brief Bioinform; 2018 Nov; 19(6):1085-1101. PubMed ID: 28498882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention.
    Poon SL; McPherson JR; Tan P; Teh BT; Rozen SG
    Genome Med; 2014; 6(3):24. PubMed ID: 25031618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dynamics of Somatic Mutagenesis During Life in Humans.
    Manders F; van Boxtel R; Middelkamp S
    Front Aging; 2021; 2():802407. PubMed ID: 35822044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B
    Fedeles BI; Essigmann JM
    DNA Repair (Amst); 2018 Nov; 71():12-22. PubMed ID: 30309820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RepairSig: Deconvolution of DNA damage and repair contributions to the mutational landscape of cancer.
    Wojtowicz D; Hoinka J; Amgalan B; Kim YA; Przytycka TM
    Cell Syst; 2021 Oct; 12(10):994-1003.e4. PubMed ID: 34375586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.
    Hollstein M; Alexandrov LB; Wild CP; Ardin M; Zavadil J
    Oncogene; 2017 Jan; 36(2):158-167. PubMed ID: 27270430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative procedures for health risk assessment.
    Lohman PH
    Mutat Res; 1999 Jul; 428(1-2):237-54. PubMed ID: 10517997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling Mutation Spectra of Human Carcinogens Using Experimental Systems.
    Zhivagui M; Korenjak M; Zavadil J
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121 Suppl 3():16-22. PubMed ID: 27754614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hawk-Seq™ differentiates between various mutations in Salmonella typhimurium TA100 strain caused by exposure to Ames test-positive mutagens.
    Otsubo Y; Matsumura S; Ikeda N; Morita O
    Mutagenesis; 2021 Jul; 36(3):245-254. PubMed ID: 33590004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton and alpha radiation-induced mutational profiles in human cells.
    Delhomme TM; Munteanu M; Buonanno M; Grilj V; Biayna J; Supek F
    Sci Rep; 2023 Jun; 13(1):9791. PubMed ID: 37328655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.